Gotham Makker - 13 Jun 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact
Issuer symbol
RCKT
Transactions as of
13 Jun 2022
Net transactions value
+$39,957
Form type
4
Filing time
15 Jun 2022, 21:07:39 UTC
Previous filing
09 Mar 2022
Next filing
26 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +47,745 $0.000000 47,745 13 Jun 2022 Common Stock 47,745 $10.77 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $39,957 +5,876 $6.80 5,876 13 Jun 2022 Common Stock 5,876 $10.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023.
F2 This option represents a right to purchase a total of 5,876 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023. This option was issued to the Reporting Person in lieu of director retainer fees of $40,000.